Clinical Trials Browser

Phase 3 × Breast Neoplasms × Adrenal Cortex Hormones × Clear all

NCT00661102 2016-11-02

A Study of Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).

Phase 3 Completed

Breast Neoplasms